Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Perfuze, Ltd. — Predicate Candidate Screening

10 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

91 daysmedian FDA review time
267 days90th percentile
10clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K253901Millipede88 Access CatheterPerfuze, Ltd.2026-07-092160
K253590Millipede SystemPerfuze, Ltd.2026-03-161190
K252392Millipede70 Aspiration Catheter; Perfuze Aspiration Tube SetPerfuze, Ltd.2025-08-29290
K250012Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube SPerfuze, Ltd.2025-02-26550
K240711Zipline Access CatheterPerfuze, Ltd.2024-10-172160
K242504Millipede 088 Access Catheter; Millipede 070 Aspiration CathPerfuze, Ltd.2024-09-20290
K233648Millipede 088 Access CatheterPerfuze, Ltd.2023-12-14300
K232524Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube SPerfuze, Ltd.2023-10-18610
K231802Millipede 088 Access CatheterPerfuze, Ltd.2023-09-19910
K214048Millipede 088 Access CatheterPerfuze, Ltd.2022-09-202670

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda